Literature DB >> 8178827

Predisposition for breast cancer in carriers of constitutional translocation 11q;22q.

A Lindblom1, K Sandelin, L Iselius, J Dumanski, I White, M Nordenskjöld, C Larsson.   

Abstract

A translocation between the long arms of chromosomes 11 and 22, t(11;22)(q23;q11), is the most frequent constitutional reciprocal translocation in man. This chromosome abnormality has not previously been reported to be associated with an increased risk for neoplasia. The observation of one patient with a constitutional translocation t(11q;22q) and breast cancer prompted us to study the relationship between these two conditions. The incidence of breast cancer was determined in carriers of t(11q;22q). The karyotypes were determined by QFQ-banding, and the breakpoints were then further characterized by fluorescent in situ hybridization. Eight families with a total of 22 balanced carriers were found. In five of these families there was one case of breast cancer each. In another family a case of an unknown malignancy was reported in one member. No other malignancies were found among these patients. The number of breast cancer cases was significantly higher than expected among the translocation carriers (P < .001). The chromosomal breakpoints showed the same localization with the markers used, in the seven families studied. The association of constitutional translocation t(11q;22q) and breast cancer identifies a subset of patients with a highly increased risk for breast cancer who would benefit from counseling and screening. It also suggests the involvement of genes on 11q and/or 22q, in the tumorigenesis of breast cancer.

Entities:  

Mesh:

Year:  1994        PMID: 8178827      PMCID: PMC1918254     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  29 in total

1.  Functional complementation of ataxia-telangiectasia group D (AT-D) cells by microcell-mediated chromosome transfer and mapping of the AT-D locus to the region 11q22-23.

Authors:  C Lambert; R A Schultz; M Smith; C Wagner-McPherson; L D McDaniel; T Donlon; E J Stanbridge; E C Friedberg
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

2.  Familial breast-ovarian cancer locus on chromosome 17q12-q23.

Authors:  S A Narod; J Feunteun; H T Lynch; P Watson; T Conway; J Lynch; G M Lenoir
Journal:  Lancet       Date:  1991-07-13       Impact factor: 79.321

3.  Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome.

Authors:  S Srivastava; Z Q Zou; K Pirollo; W Blattner; E H Chang
Journal:  Nature       Date:  1990 Dec 20-27       Impact factor: 49.962

4.  Linkage of early-onset familial breast cancer to chromosome 17q21.

Authors:  J M Hall; M K Lee; B Newman; J E Morrow; L A Anderson; B Huey; M C King
Journal:  Science       Date:  1990-12-21       Impact factor: 47.728

5.  Isolation and mapping of polymorphic cosmid clones used for sublocalization of the multiple endocrine neoplasia type 1 (MEN1) locus.

Authors:  C Larsson; G Weber; E Kvanta; K Lewis; M Janson; C Jones; T Glaser; G Evans; M Nordenskjöld
Journal:  Hum Genet       Date:  1992-05       Impact factor: 4.132

6.  The elastin gene is disrupted by a translocation associated with supravalvular aortic stenosis.

Authors:  M E Curran; D L Atkinson; A K Ewart; C A Morris; M F Leppert; M T Keating
Journal:  Cell       Date:  1993-04-09       Impact factor: 41.582

7.  Loss of heterozygosity in familial breast carcinomas.

Authors:  A Lindblom; L Skoog; S Rotstein; B Werelius; C Larsson; M Nordenskjöld
Journal:  Cancer Res       Date:  1993-09-15       Impact factor: 12.701

8.  Cloning and characterization of the Ewing's sarcoma and peripheral neuroepithelioma t(11;22) translocation breakpoints.

Authors:  J Zucman; O Delattre; C Desmaze; B Plougastel; I Joubert; T Melot; M Peter; P De Jong; G Rouleau; A Aurias
Journal:  Genes Chromosomes Cancer       Date:  1992-11       Impact factor: 5.006

9.  A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome.

Authors:  R Wooster; J Mangion; R Eeles; S Smith; M Dowsett; D Averill; P Barrett-Lee; D F Easton; B A Ponder; M R Stratton
Journal:  Nat Genet       Date:  1992-10       Impact factor: 38.330

10.  Complete characterization of a large marker chromosome by reverse and forward chromosome painting.

Authors:  E Blennow; H Telenius; C Larsson; D de Vos; S Bajalica; B A Ponder; M Nordenskjöld
Journal:  Hum Genet       Date:  1992-12       Impact factor: 4.132

View more
  11 in total

1.  Tightly clustered 11q23 and 22q11 breakpoints permit PCR-based detection of the recurrent constitutional t(11;22).

Authors:  H Kurahashi; T H Shaikh; E H Zackai; L Celle; D A Driscoll; M L Budarf; B S Emanuel
Journal:  Am J Hum Genet       Date:  2000-07-20       Impact factor: 11.025

2.  A unique case of der(11)t(11;22),-22 arising from 3:1 segregation of a maternal t(11;22) in a family with co-segregation of the translocation and breast cancer.

Authors:  Vaidehi Jobanputra; Wendy K Chung; April M Hacker; Beverly S Emanuel; Dorothy Warburton
Journal:  Prenat Diagn       Date:  2005-08       Impact factor: 3.050

3.  The effect of translocation-induced nuclear reorganization on gene expression.

Authors:  Louise Harewood; Frédéric Schütz; Shelagh Boyle; Paul Perry; Mauro Delorenzi; Wendy A Bickmore; Alexandre Reymond
Journal:  Genome Res       Date:  2010-03-08       Impact factor: 9.043

Review 4.  Familial breast cancer and genes involved in breast carcinogenesis.

Authors:  A Lindblom
Journal:  Breast Cancer Res Treat       Date:  1995-05       Impact factor: 4.872

5.  Hereditary breast and ovarian cancer.

Authors:  Jacek Gronwald; Tomasz Byrski; Tomasz Huzarski; Oleg Oszurek; Anna Janicka; Jolanta Szymanska-Pasternak; Bohdan Górski; Janusz Menkiszak; Izabella Rzepka-Górska; Jan Lubinski
Journal:  Hered Cancer Clin Pract       Date:  2008-06-15       Impact factor: 2.857

6.  Risk of breast cancer not increased in translocation 11;22 carriers: analysis of 80 pedigrees.

Authors:  Melissa T Carter; Nicholas J Barrowman; Stephanie A St Pierre; Beverly S Emanuel; Kym M Boycott
Journal:  Am J Med Genet A       Date:  2010-01       Impact factor: 2.802

7.  Loss of heterozygosity at chromosome 11 in breast cancer: association of prognostic factors with genetic alterations.

Authors:  J Gudmundsson; R B Barkardottir; G Eiriksdottir; T Baldursson; A Arason; V Egilsson; S Ingvarsson
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

8.  Detailed deletion mapping at chromosome 11q23 in colorectal carcinoma.

Authors:  A S Lee; Y C Seo; A Chang; S Tohari; K W Eu; F Seow-Choen; J O McGee
Journal:  Br J Cancer       Date:  2000-09       Impact factor: 7.640

9.  European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables. Breast Cancer Somatic Genetics Consortium.

Authors:  V Launonen; K Laake; P Huusko; D Niederacher; M W Beckmann; R B Barkardottir; E K Geirsdottir; J Gudmundsson; P Rio; Y J Bignon; S Seitz; S Scherneck; I Bièche; M H Champème; D Birnbaum; G White; J Varley; M Sztán; E Olah; A Osorio; J Benitez; N Spurr; N Velikonja; B Peterlin; R Winqvist
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

10.  Intravascular Large B-cell Lymphoma of the Bilateral Ovaries and Uterus in an Asymptomatic Patient with a t(11;22)(q23;q11) Constitutional Translocation.

Authors:  Yasuyuki Shigematsu; Motoki Matsuura; Noriko Nishimura; Naoko Tsuyama; Kengo Takeuchi; Yasuhito Terui; Nobuhiro Takeshima; Kiyohiko Hatake
Journal:  Intern Med       Date:  2016-11-01       Impact factor: 1.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.